A Randomized, Multi-center, Parallel Group, Double Blind, Placebo and Formoterol Controlled 14 Day Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER Device in Patients With COPD
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2015
At a glance
- Drugs Indacaterol (Primary) ; Formoterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Novartis
- 09 Dec 2009 Additional location (Norway) added as reported by ClinicalTrials.gov
- 08 Apr 2009 Actual patient number (568) added as reported by ClinicalTrials.gov.
- 08 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.